← SynDRA
AMBENONIUM
SynDRA canonical compound SYN0016288 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | ACHE |
|---|
| Mechanism of action | Cholinesterase inhibitor |
|---|
| Indication | myasthenia gravis |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- Cholinesterase inhibitor
- ACHE INHIBITOR
- Acetylcholinesterase inhibitor
Drug classes
- Cholinesterase Inhibitors
- Cholinergic Agents
- Enzyme Inhibitors
- Neurotransmitter Agents
- Parasympathomimetics
- Peripheral Nervous System Agents
- Cholinesterase Inhibitor
ATC classes
- N07A · PARASYMPATHOMIMETICS
Cross-references
Synonyms
- ambenonium chloride
- ambestigmin chloride
- mytelase chloride
- mytelase
- Ambenonium cation
- Ambenonium ion
- Ambenonum
- Ambenonium Base
- Ambenonium kation
- Mytelase (TN)
- (2-chlorophenyl)methyl-[2-[[2-[2-[(2-chlorophenyl)methyl-diethylazaniumyl]ethylamino]-2-oxoacetyl]amino]ethyl]-diethylazanium
- 2,2'-[(1,2-dioxoethane-1,2-diyl)diimino]bis[n-(2-chlorobenzyl)-n,n-diethylethanaminium]
- Ambenonium [USAN]
- L16PUN799N
- AMBENONIUM [VANDF]
- AMBENONIUM [WHO-DD]
- CHEBI:2627
- OXALYLBIS(IMINOETHYLENE))BIS((O-CHLOROBENZYL)DIETHYLAMMONIUM
- RefChem:556872
- DTXCID6028369
- NCGC00163221-01
- UNII-L16PUN799N
- Tocris-0388
- SCHEMBL284678
- orb1737736
- BDBM50262988
- STL430453
- AKOS037479279
- NCGC00024567-01
- NCGC00024567-02
- NS00069747
- C07773
- BRD-K11292736-300-02-8
- Ambenonium base
- Ambenonium dichloride
- Mytelase
- Оксазил
- Амбенонію хлорид
Look up AMBENONIUM in the interactive SynDRA portal →